These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 29528583)

  • 1. Circulating Fibroblast Growth Factors 21 and 23 as Biomarkers of Progression in Diabetic Nephropathy in Type 2 Diabetes with Normoalbuminuria.
    El-Saeed AM; El-Mohasseb GF
    Egypt J Immunol; 2017 Jun; 24(2):93-99. PubMed ID: 29528583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating fibroblast growth factor 21 levels predict progressive kidney disease in subjects with type 2 diabetes and normoalbuminuria.
    Lee CH; Hui EY; Woo YC; Yeung CY; Chow WS; Yuen MM; Fong CH; Xu A; Lam KS
    J Clin Endocrinol Metab; 2015 Apr; 100(4):1368-75. PubMed ID: 25625802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [ASSOCIATION OF FIBROBLAST GROWTH FACTOR 23 WITH MARKERS OF INFLAMMATION AND FIBROSIS IN DIABETIC NEPHROPATHY].
    Topchii I; Semenovykh P; Galchiskaya V; Yakymenko Y; Shcherban T
    Georgian Med News; 2019; (292-293):44-49. PubMed ID: 31560661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating levels of fibroblast growth factor 21 in early-stage diabetic kidney disease.
    Esteghamati A; Khandan A; Momeni A; Behdadnia A; Ghajar A; Nikdad MS; Noshad S; Nakhjavani M; Afarideh M
    Ir J Med Sci; 2017 Aug; 186(3):785-794. PubMed ID: 28181108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between serum fibroblast growth factor 21 and diabetic nephropathy.
    Jian WX; Peng WH; Jin J; Chen XR; Fang WJ; Wang WX; Qin L; Dong Y; Su Q
    Metabolism; 2012 Jun; 61(6):853-9. PubMed ID: 22136913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidermal growth factor receptor and podocin predict nephropathy progression in type 2 diabetic patients through interaction with the autophagy influencer ULK-1.
    El-Shazly AAA; Sallam AM; El-Hefnawy MH; El-Mesallamy HO
    J Diabetes Complications; 2019 Feb; 33(2):128-133. PubMed ID: 30545560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of glycated LDL in different stages of diabetic nephropathy.
    Siddiqui K; George TP; Nawaz SS; Yaslam M; Almogbel E; Al-Rubeaan K
    Diabetes Metab Syndr; 2019; 13(1):548-552. PubMed ID: 30641763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pathophysiological factors in the development of diabetic nephropathy--new insights].
    Blaslov K; Bulum T; Duvnjak L
    Acta Med Croatica; 2014 Apr; 68(2):135-40. PubMed ID: 26012151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Higher serum betatrophin level in type 2 diabetes subjects is associated with urinary albumin excretion and renal function.
    Chen CC; Susanto H; Chuang WH; Liu TY; Wang CH
    Cardiovasc Diabetol; 2016 Jan; 15():3. PubMed ID: 26739836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. E-cadherin and periostin in early detection and progression of diabetic nephropathy: epithelial-to-mesenchymal transition.
    El-Dawla NMQ; Sallam AM; El-Hefnawy MH; El-Mesallamy HO
    Clin Exp Nephrol; 2019 Aug; 23(8):1050-1057. PubMed ID: 31104272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ApoM/HDL-C and apoM/apoA-I ratios are indicators of diabetic nephropathy in healthy controls and type 2 diabetes mellitus.
    Zhang P; Gao J; Pu C; Feng G; Wang L; Huang L; Zhang Y
    Clin Chim Acta; 2017 Mar; 466():31-37. PubMed ID: 28073663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble Klotho and fibroblast growth factor 23 levels in diabetic nephropathy with different stages of albuminuria.
    Inci A; Sari F; Coban M; Olmaz R; Dolu S; Sarıkaya M; Yılmaz N
    J Investig Med; 2016 Aug; 64(6):1128-33. PubMed ID: 27323770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma endoglin in Type2 diabetic patients with nephropathy.
    Doghish AS; Bassyouni AA; Mahfouz MH; Abd El-Aziz HG; Zakaria RY
    Diabetes Metab Syndr; 2019; 13(1):764-768. PubMed ID: 30641803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The U-shaped relationship between fibroblast growth factor 21 and microvascular complication in type 2 diabetes mellitus.
    Jung CH; Jung SH; Kim BY; Kim CH; Kang SK; Mok JO
    J Diabetes Complications; 2017 Jan; 31(1):134-140. PubMed ID: 27839924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating Levels of Soluble Klotho and Fibroblast Growth Factor 23 in Diabetic Patients and Its Association with Early Nephropathy.
    Farías-Basulto A; Martínez-Ramírez HR; Gómez-García EF; Cueto-Manzano AM; Cortés-Sanabria L; Hernández-Ramos LE; Ramírez-López G; Mendoza-Carrera F
    Arch Med Res; 2018 Oct; 49(7):451-455. PubMed ID: 30718148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression Level of Circulating Cell Free miR-155 Gene in Serum of Patients with Diabetic Nephropathy.
    Akhbari M; Khalili M; Shahrabi-Farahani M; Biglari A; Bandarian F
    Clin Lab; 2019 Aug; 65(8):. PubMed ID: 31414764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ALCAM a novel biomarker in patients with type 2 diabetes mellitus complicated with diabetic nephropathy.
    Sulaj A; Kopf S; Gröne E; Gröne HJ; Hoffmann S; Schleicher E; Häring HU; Schwenger V; Herzig S; Fleming T; Nawroth PP; von Bauer R
    J Diabetes Complications; 2017 Jun; 31(6):1058-1065. PubMed ID: 28325697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary platelet-derived growth factor-BB as an early marker of nephropathy in patients with type 2 diabetes: an Egyptian study.
    Bessa SS; Hussein TA; Morad MA; Amer AM
    Ren Fail; 2012; 34(6):670-5. PubMed ID: 22486214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum fibroblast growth factor 21 concentrations in type 2 diabetic retinopathy patients.
    Esteghamati A; Momeni A; Abdollahi A; Khandan A; Afarideh M; Noshad S; Nakhjavani M
    Ann Endocrinol (Paris); 2016 Oct; 77(5):586-592. PubMed ID: 27106505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta2-microglobulin and cystatin C in type 2 diabetes: assessment of diabetic nephropathy.
    Aksun SA; Ozmen D; Ozmen B; Parildar Z; Mutaf I; Turgan N; Habif S; Kumanlioğluc K; Bayindir O
    Exp Clin Endocrinol Diabetes; 2004 Apr; 112(4):195-200. PubMed ID: 15127324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.